Literature DB >> 3113806

Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.

P K Noonan, L Z Benet.   

Abstract

Plasma concentrations of 1,2- and 1,3-glyceryl dinitrates were measured in each of four healthy volunteers who received intravenous infusions (10, 20, and 40 micrograms/min), topical ointment (20 mg/200 cm2), and oral solution (6.5 mg) doses of nitroglycerin and from two subjects who received sublingual (0.4 mg) nitroglycerin. The ratio of 1,2-glyceryl dinitrate to 1,3-glyceryl dinitrate (dinitrate ratio) was determined for each subject after each dose and was found to vary with route of administration. Dinitrate ratios were 7.36, 4.60, 3.86, and 1.99 for intravenous, sublingual, topical, and oral doses, respectively. Nonspecific metabolism of nitroglycerin would result in twice as much of the 1,2-dinitrate as the 1,3-dinitrate (i.e., a dinitrate ratio of 2.0, such as that produced after oral administration). A high ratio (e.g., after intravenous administration) indicates that the metabolism was more specific. These results indicate that metabolite formation depends on route of administration, implying different metabolic specificity of enzymes in the gut, liver, skin, sublingual mucosa, and blood vessels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113806     DOI: 10.1038/clpt.1987.146

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers.

Authors:  M Gumbleton; L Z Benet
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.

Authors:  E Nakashima; P K Noonan; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

3.  Effect of short-acting nitroglycerin on heart rate: evaluation by a self-monitoring device.

Authors:  J T Lahtela; E A Sotaniemi
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

4.  Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.

Authors:  N Higo; R S Hinz; D T Lau; L Z Benet; R H Guy
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

Review 5.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.

Authors:  E Nakashima; D T Lau; L Z Benet
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

Review 7.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

8.  Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.

Authors:  R L Williams; K M Thakker; V John; E T Lin; W Liang-Gee; L Z Benet
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

9.  Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.

Authors:  T Kikkoji; M Gumbleton; N Higo; R H Guy; L Z Benet
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

10.  Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin.

Authors:  H K Iversen; T H Nielsen; P Tfelt-Hansen; J Olesen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.